-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OLxKjSb4mWhWCi+BIbjqVnbN5RpNntNH0nhvAX9OTqj0dKzhEiq9YqRIHuMfFJLD
 B2byFVlzi9y+kHvN4yVSrw==

<SEC-DOCUMENT>0000878088-08-000018.txt : 20080117
<SEC-HEADER>0000878088-08-000018.hdr.sgml : 20080117
<ACCEPTANCE-DATETIME>20080117160514
ACCESSION NUMBER:		0000878088-08-000018
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080111
FILED AS OF DATE:		20080117
DATE AS OF CHANGE:		20080117

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PAR PHARMACEUTICAL COMPANIES, INC.
		CENTRAL INDEX KEY:			0000878088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				223122182
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		300 TICE BOULEVARD
		CITY:			WOODCLIFF LAKE
		STATE:			NJ
		ZIP:			07677
		BUSINESS PHONE:		201-802-4000

	MAIL ADDRESS:	
		STREET 1:		300 TICE BOULEVARD
		CITY:			WOODCLIFF LAKE
		STATE:			NJ
		ZIP:			07677

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHARMACEUTICAL RESOURCES INC
		DATE OF NAME CHANGE:	19940526

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MacPhee John A
		CENTRAL INDEX KEY:			0001339976

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10827
		FILM NUMBER:		08536165

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		(201) 802-4000

	MAIL ADDRESS:	
		STREET 1:		C/O PAR PHARMACEUTICAL COMPANIES, INC.
		STREET 2:		300 TICE BOULEVARD
		CITY:			WOODCLIFF LAKE
		STATE:			NJ
		ZIP:			07677
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2008-01-11</periodOfReport>

    <dateOfOriginalSubmission>2008-01-15</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000878088</issuerCik>
        <issuerName>PAR PHARMACEUTICAL COMPANIES, INC.</issuerName>
        <issuerTradingSymbol>PRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001339976</rptOwnerCik>
            <rptOwnerName>MacPhee John A</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PAR PHARMACEUTICAL COMPANIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>300 TICE BOULEVARD</rptOwnerStreet2>
            <rptOwnerCity>WOODCLIFF LAKE</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07677</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>EVP, Pres Strativa Pharm Div</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2008-01-11</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>36849</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>105534</value>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">This Amendment is being filed to correct the clerical error in the number of shares of Restricted Stock awarded under the Company's 2004 Performance Equity Plan as previously reported in Column 4 of Table I.  33% of the shares of Restricted Stock vest as follows:  25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary thereafter until the 33% are fully vested; 67% of the shares of Restricted Stock vest as follows:  over a three-year period, upon the achievement by the Company of defined goals of Total Returns to Shareholders relative to a defined peer group of pharmaceutical companies.</footnote>
        <footnote id="F2">The closing price of the Company's Common Stock as reported by The New York Stock Exchange, Inc. on the date of grant was $21.71.</footnote>
        <footnote id="F3">This Amendment is being filed to correct the total number of securities beneficially owned in Column 5 of Table I; includes all outstanding shares of Restricted Stock and Restricted Stock Units held by Mr. MacPhee.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Marian E. Gustafson for John A. MacPhee</signatureName>
        <signatureDate>2008-01-17</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----